U.S. Markets open in 1 hr 20 mins

Would Art's-Way Manufacturing (NASDAQ:ARTW) Be Better Off With Less Debt?

Simply Wall St

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. It's only natural to consider a company's balance sheet when you examine how risky it is, since debt is often involved when a business collapses. We can see that Art's-Way Manufacturing Co., Inc. (NASDAQ:ARTW) does use debt in its business. But is this debt a concern to shareholders?

Why Does Debt Bring Risk?

Generally speaking, debt only becomes a real problem when a company can't easily pay it off, either by raising capital or with its own cash flow. Ultimately, if the company can't fulfill its legal obligations to repay debt, shareholders could walk away with nothing. While that is not too common, we often do see indebted companies permanently diluting shareholders because lenders force them to raise capital at a distressed price. Of course, the upside of debt is that it often represents cheap capital, especially when it replaces dilution in a company with the ability to reinvest at high rates of return. When we think about a company's use of debt, we first look at cash and debt together.

Check out our latest analysis for Art's-Way Manufacturing

What Is Art's-Way Manufacturing's Net Debt?

The chart below, which you can click on for greater detail, shows that Art's-Way Manufacturing had US$5.37m in debt in August 2019; about the same as the year before. Net debt is about the same, since the it doesn't have much cash.

NasdaqCM:ARTW Historical Debt, October 25th 2019

How Healthy Is Art's-Way Manufacturing's Balance Sheet?

Zooming in on the latest balance sheet data, we can see that Art's-Way Manufacturing had liabilities of US$6.57m due within 12 months and liabilities of US$2.37m due beyond that. Offsetting these obligations, it had cash of US$5.0k as well as receivables valued at US$2.74m due within 12 months. So its liabilities total US$6.20m more than the combination of its cash and short-term receivables.

This is a mountain of leverage relative to its market capitalization of US$8.45m. Should its lenders demand that it shore up the balance sheet, shareholders would likely face severe dilution. There's no doubt that we learn most about debt from the balance sheet. But you can't view debt in total isolation; since Art's-Way Manufacturing will need earnings to service that debt. So when considering debt, it's definitely worth looking at the earnings trend. Click here for an interactive snapshot.

Over 12 months, Art's-Way Manufacturing made a loss at the EBIT level, and saw its revenue drop to US$19m, which is a fall of 8.7%. That's not what we would hope to see.

Caveat Emptor

Importantly, Art's-Way Manufacturing had negative earnings before interest and tax (EBIT), over the last year. Its EBIT loss was a whopping US$2.8m. Considering that alongside the liabilities mentioned above does not give us much confidence that company should be using so much debt. So we think its balance sheet is a little strained, though not beyond repair. However, it doesn't help that it burned through US$749k of cash over the last year. So in short it's a really risky stock. For riskier companies like Art's-Way Manufacturing I always like to keep an eye on the long term profit and revenue trends. Fortunately, you can click to see our interactive graph of its profit, revenue, and operating cashflow.

If you're interested in investing in businesses that can grow profits without the burden of debt, then check out this free list of growing businesses that have net cash on the balance sheet.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.